CSI Market
Sign In | Register

Arbutus Biopharma (ABUS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABUS Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Arbutus Biopharma manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent16.99
Short-term Investments, Total0.01
Short-term Investments68.23
Cash & Short-term Investments84.00
Accounts receivable128.10
Unbilled Receivables, Current RE0.30
Other Current Assets1.31
Prepaid Expense And Other Assets Current1.73
Total Current Assets198.53
Equipment/Property/Plant Net0.22
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.13
Operating Lease Right Of Use Asset-
Total Assets198.64
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.21
Accrued Liabilities, Current1.57
Other Liabilities, Current0.63
Deferred Revenue, Current DE0.00
Total Current Liabilities3.66
Total Long-term Debt0.00
Restructuring Reserve, Current RE0.25
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent6.52
Operating Lease Liability Current0.63
Liability Related To Sale Of Future Royalties Noncurrent3.28
Total Liabilities12.17
Stockholders' Equity
Common Stock Value1,035.26
Additional Paid In Capital Common Stock53.22
Retained Earnings / Accumulated Deficit-867.47
Accumulated Other Comprehensive Income-34.54
Other Equity-34.54
Common Stockholder's Equity186.47
Total Stockholder's Equity186.47
Liabilities & Stockholder's Equity198.64
4 historic quarters locked

Sign in to unlock the full Arbutus Biopharma balance sheet history.

Sign In Create Free Account

About Arbutus Biopharma Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001447028-26-000045

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.